Skip to content

Multicenter study of usefulness of the target protein as a novel tumor marker for ovarian clear cell carcinoma

Multicenter study of usefulness of the target protein as a novel tumor marker for ovarian clear cell carcinoma - Usefulness of a novel tumor marker for ovarian clear cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022827
Enrollment
250
Registered
2016-06-27
Start date
2016-06-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients suspected of epithelial ovarian bordeline tummors or epithelial ovarian cancers by diagnostic imaging 2. Patients who submitted the document for written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with simultaneous malignancies or previous history of malignancies 2. Patients who are judged as being inappropriate for the participation in this study 3. Patients during pregnancy

Design outcomes

Primary

MeasureTime frame
Specificity of the target protein to detect ovarian clear cell carcinoma

Countries

Japan

Contacts

Public ContactRuiz Yokota Naho

Yokohama City University Department of Obstetrics and Gynecology

nhyokota@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026